(University of Kentucky) To date, there have been very few successes in the pursuit of a treatment for Alzheimer's disease. But one drug that looks at AD from a different angle is now ready for its first round of testing in humans, supported by $5.5 million from the NIH and the ADDF.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2FU8IvS
No comments:
Post a Comment